Vir Biotechnology, Inc. (VIR) Total liabilities 2018–2025
Vir Biotechnology, Inc. (VIR) total liabilities at each fiscal year-end, per SEC filings.
$237.5MFY2025 · since FY2018: $61.6M → $237.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $237.5M | -4.4% |
| FY2024 | $248.4M | -24.4% |
| FY2023 | $328.8M | -54.6% |
| FY2022 | $724.1M | +38.6% |
| FY2021 | $522.4M | +158.7% |
| FY2020 | $201.9M | +129.1% |
| FY2019 | $88.1M | +43.0% |
| FY2018 | $61.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice